Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
Loading

Update No. 119

Note to subscribers for the amendments to

the rules governing the listing of securities (the "Listing Rules")

Update No. 119

 

April 2018

Dear Sirs,

Amendments to the Main Board Listing Rules

We enclose reprinted pages of the Listing Rules and filing instructions. The reprinted pages incorporate amendments to implement the proposals of the "Consultation Conclusions Paper on a Listing Regime for Companies from Emerging and Innovative Sectors" published on 24 April 2018.
 
We have amended the Listing Rules to: 
 
B02A24241D934714AD273561037F6D6D  permit listings of Biotech Companies that do not meet any of the Main Board financial eligibility tests;
   
B02A24241D934714AD273561037F6D6D permit listings of companies with weighted voting right structures; and
   
B02A24241D934714AD273561037F6D6D establish a new concessionary secondary listing route for Greater China and international companies that wish to secondary list in Hong Kong.
 
Coming into effect
 
The amendments will come into effect on 30 April 2018.
 
Please click HERE to see the amendment to the Listing Rules.

 

Yours faithfully,

For and on behalf of
The Stock Exchange of Hong Kong Limited

David Graham
Chief Regulatory Officer and Head of Listing